Recombinant factor VIIa to treat late radiation-induced hemorrhagic cystitis: A case report

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 53, Issue 5, 2008, Pages 360-362

  Geisler, John P ^a,b   Linnemeier, Georgiann C ^a   Manahan, Kelly J ^a  

^a St Vincent Hospital   (United States)

^b Indiana Women's Oncology PC   (United States)

Author keywords

Cervical cancer; Hemorrhagic cystitis; Hyperbaric oxygen; Radiation complications

Indexed keywords

ALPHA TOCOPHEROL; ALUMINUM HYDROXIDE; FORMALDEHYDE; MAGNESIUM HYDROXIDE; PENTOXIFYLLINE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; SILVER NITRATE;

ADULT; ARTICLE; BLADDER IRRIGATION; CASE REPORT; ERYTHROCYTE CONCENTRATE; FEMALE; HEMORRHAGIC CYSTITIS; HUMAN; HYPERBARIC OXYGEN; PRIORITY JOURNAL; RADIATION INJURY; UTERINE CERVIX CANCER;

ADULT; CYSTITIS; FACTOR VIIA; FEMALE; HEMORRHAGE; HUMANS; PELVIC NEOPLASMS; RADIOTHERAPY; RECOMBINANT PROTEINS;

EID: 45349084747     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Denton A, Forbes A, Andreyev J, et al: Nonsurgical interventions for late radiation proctitis in patients who have received radical radiotherapy to the pelvis. Cochrane Data System Rev [serial online] 2006;1:CD003455
2. Cantwell BM, Harris AL, Patrick D, et al: Hemorrhagic cystitis after i.v. bleomycin, vinblastine, cisplatin, and etoposide for testicular cancer. Cancer Treat Rep 1986;70:548-549
3. Rowinsky EK, Grochow LB, Hendricks CB, et al: Phase I and pharmacologic study of topotecan: A novel topoisomerase I inhibitor. J Clin Oncol 1992;10:647-656
4. Chong KT, Hampson NB, Corman JM: Early hyperbaric oxygen therapy improves outcome for radiation-induced hemorrhagic cystitis. Urology 2005;65:649-653
5. Corman JM, McClure D, Pritchett R, et al: Treatment of radiation induced hemorrhagic cystitis with hyperbaric oxygen. J Urol 2003;169:2200-2202
6. Karimi M, Zakerinia M, Khojasteh HN, et al: Successful treatment of cyclophosphamide induced intractable hemorrhagic cystitis with recombinant FVIIa (NovoSeven) after allogenic bone marrow transplantation. J Thromb Haemost 2004;2:1853-1855
7. De Gasperi A: Intraoperative use of recombinant activated factor VIIA (rFVIIAa). Minerva Anestesiol 2006;72:489-494
8. Marietta M, Facchini L, Pedrazzi P, et al: Pathophysiology of bleeding in surgery. Transplant Proc 2006;38:812-814
9. White MC, Pryn SJ, Monk CR: Thrombogenic side-effects of recombinant factor VIIa after use in coronary artery bypass surgery. Anaesth Intensive Care 2006;34:664-667
10. Friederich PW, Henny CP, Messelink EJ, et al: Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: A double-blind placebo-controlled randomised trial. Lancet 2003;61: 201-205